ID

40562

Description

ADVANCED PROSTATE CANCER DATA COLLECTION Version 2.3.1 Revised: April 10th, 2017 International Consortium for Health Outcomes Measurement (ICHOM), Source: http://www.ichom.org/ Notice: This work was conducted using resources from ICHOM, the International Consortium for Health Outcomes Measurement (www.ICHOM.org). The content is solely the responsibility of the authors and does not necessarily represent the official views of ICHOM. Conditions: All patients with advanced prostate cancer, either having metastatic disease or biochemical recurrence progressing after salvage treatment or ineligible for salvage treatment. Patients with biochemical recurrence treated with salvage therapy are referred to the localized prostate cancer set. Treatment Approaches: Hormonal Therapy | Chemotherapy | Immunotherapy | Radiopharmaceuticals | Radiation | Interventions for Complications of Local Progression This form contains clinical varibales to be assessed at baseline (Baseline index event: diagnosis of advanced Disease: Diagnosed with LPC, progresses to biochemical recurrence and is not eligible for salvage thearpy or has been treated with salvage thearpy; Diagnosed with LPC, progresses to metastatic disease; Diagnosed with metastatic disease at time of diagnosis). Questionnaires used in this standard set: Expanded Prostate Cancer Index Composite (EPIC-26): The EPIC-26 is free for all health care organizations, and a license is not needed. The scoring guide may be found at http://www.med.umich.edu/urology/research/EPIC/EPIC-26-Scoring-1.2007.pdf ; Wei J, Dunn R, Litwin M, Sandler H, and Sanda M. "Development and Validation of the Expanded Prostate Cancer Index Composite (EPIC) for Comprehensive Assessment of Health-Related Quality of Life in Men with Prostate Cancer", Urology. 56: 899-905, 2000. For registries choosing to implement the EPIC‐CP rather than the EPIC‐26, we recommend using the same variable IDs as the corresponding EPIC‐26 questions. This means that only questions 2, 3, 4a, 4b, 4d, 4e, 5, 6e, 6b, 7, 8b, 9, 12, 13a, 13c, and 13d of the EPIC-26 are administered. Utilization of Sexual Medications/Devices: The Utilization of Sexual Medications/Devices is free for all health care organizations, and a license is not needed (according to ICHOM). Refer to http://dx.doi.org/10.1016/j.urology.2006.01.077 for more information European Organization for Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ-C30): For use of the EORTC QLQ-C30 a license is needed, therefore the questions will not be part of this version of the standard set. (eortc.be) The following paper has been published about development of this standard set: Morgans AK, van Bommel ACM, Stowell C, Abrahm JL, Basch E, Bekelman JE, et al. Development of a Standardized Set of Patient-centered Outcomes for Advanced Prostate Cancer: An International Effort for a Unified Approach. Eur Urol. 2015 Nov;68(5):891–8. For the standard set ICHOM has been supported by the Movember Foundation. For this version of the standard set, semantic annotation with UMLS CUIs has been added.

Link

http://www.ichom.org/

Keywords

Versions (2)
  1. 11/29/18 11/29/18 - Sarah Riepenhausen
  2. 4/30/20 4/30/20 - Sarah Riepenhausen
Copyright Holder

ICHOM

Uploaded on

April 30, 2020

DOI

To request one please log in.

License

Creative Commons BY-NC 4.0
Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Back to model comments
Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

ICHOM Advanced Prostate Cancer

English

Baseline Clinical Form

1 forms  
  1. StudyEvent: ODM
    1. Baseline Clinical Form
Administrative Data
Description

Administrative Data

Alias
UMLS CUI-1
C1320722
Indicate the patient's medical record number
Description

This number will not be shared with ICHOM. In the case patient-level data is submitted to ICHOM for benchmarking or research purposes, a separate ICHOM Patient Identifier will be created and cross-linking between the ICHOM Patient Identifier and the medical record number will only be known at the treating institution INCLUSION CRITERIA: All patients TIMING: On all forms REPORTING SOURCE: Administrative or clinical RESPONSE OPTIONS: According to institution

Data type

integer

Alias
UMLS CUI [1]
C1269815
Demographic Factors
Description

Demographic Factors

Alias
UMLS CUI-1
C1704791
What is your date of birth?
Description

INCLUSION CRITERIA: All patients TIMING: Baseline REPORTING SOURCE: Clinical or patient-reported TYPE: Date by DD/MM/YYYY

Data type

date

Measurement units
  • DD/MM/YYYY
Alias
UMLS CUI [1]
C0421451
DD/MM/YYYY
Indicate height in centimeters or inches
Description

Height and weight are used to calculate BMI INCLUSION CRITERIA: All patients TIMING: Baseline REPORTING SOURCE: Clinical reported TYPE: Numerical value RESPONSE OPTIONS: Numerical value of height in cm or in

Data type

float

Alias
UMLS CUI [1]
C0005890
Indicate units of height
Description

INCLUSION CRITERIA: All patients TIMING: Baseline REPORTING SOURCE: Clinical reported TYPE: Single answer

Data type

integer

Alias
UMLS CUI [1,1]
C0005890
UMLS CUI [1,2]
C1519795
Indicate weight in kilograms or pounds
Description

Height and weight are used to calculate BMI INCLUSION CRITERIA: All patients TIMING: Baseline REPORTING SOURCE: Clinical reported TYPE: Numerical value RESPONSE OPTIONS: Numerical value of weight in kg or lbs

Data type

float

Alias
UMLS CUI [1]
C0005910
Indicate units of weight
Description

INCLUSION CRITERIA: All patients TIMING: Baseline REPORTING SOURCE: Clinical reported TYPE: Single answer

Data type

integer

Alias
UMLS CUI [1,1]
C0005910
UMLS CUI [1,2]
C1519795
Baseline Clinical Factors
Description

Baseline Clinical Factors

Alias
UMLS CUI-1
C0449440
UMLS CUI-2
C1442488
Indicate hemoglobin level at time of APC diagnosis
Description

INCLUSION CRITERIA: All patients TIMING: Baseline REPORTING SOURCE: Clinical TYPE: Numerical value RESPONSE OPTIONS: Numerical value of hemoglobin level in g/L

Data type

float

Measurement units
  • g/L
Alias
UMLS CUI [1,1]
C0518015
UMLS CUI [1,2]
C0011900
g/L
Baseline Tumor Factors
Description

Baseline Tumor Factors

Alias
UMLS CUI-1
C0475752
UMLS CUI-2
C1442488
Indicate PSA value at time of APC diagnosis
Description

INCLUSION CRITERIA: All patients TIMING: Baseline REPORTING SOURCE: Clinical RESPONSE OPTIONS: Numerical value of PSA ng/mL

Data type

float

Measurement units
  • ng/mL
Alias
UMLS CUI [1]
C0201544
ng/mL
Indicate the clinical tumor stage (per AJCC 7th)
Description

Pathologic staging preferred, if available cT0: No evidence of primary tumor cT1: if not able to select T1a, T1b or T1c: Clinically inapparent tumor neither palpable nor visible by imaging cT1a: Tumor incidental histologic finding in 5 percent or less of tissue resected cT1b: Tumor incidental histologic finding in more than 5 percent of tissue resected cT1c: Tumor identified by needle biopsy (eg, because of elevated PSA) cT2: if not able to select T2a, T2b or T2c: Tumor confined within prostate* cT2a: Tumor involves one-half of one lobe or less cT2b: Tumor involves more than one-half of one lobe but not both lobes cT2c: Tumor involves both lobes cT3: if not able to select T3a, T3b or T3c: Tumor extends through the prostate capsule cT3a: Extracapsular extension (unilateral or bilateral) cT3b: Tumor invades seminal vesicle(s) cT4: Tumor is fixed or invades adjacent structures other than seminal vesicles such as external sphincter, rectum, bladder, levator muscles, and/or pelvic wall cTX: Primary tumor cannot be assessed INCLUSION CRITERIA: All patients TIMING: Baseline REPORTING SOURCE: Clinical TYPE: Single answer

Data type

integer

Alias
UMLS CUI [1,1]
C0600139
UMLS CUI [1,2]
C1300072
UMLS CUI [1,3]
C0205210
Indicate the clinical nodal stage (per AJCC 7th)
Description

Pathologic staging preferred, if available cNo: regional lymph node metastasis cN1: Metastasis in regional lymph node(s) cNX: Regional lymph nodes were not assessed INCLUSION CRITERIA: All patients TIMING: Baseline REPORTING SOURCE: Clinical TYPE: Single answer

Data type

integer

Alias
UMLS CUI [1,1]
C0600139
UMLS CUI [1,2]
C0456532
UMLS CUI [1,3]
C0205210
Indicate the pathological tumor stage (per AJCC 7th)
Description

Pathologic staging preferred, if available pT2: if not able to select T2a, T2b or T2c: Organ confined pT2a: Unilateral, one-half of one side or less pT2b: Unilateral, involving more than one-half of side but not both sides pT2c: Bilateral disease pT3: if not able to select T3a, T3b: Extraprostatic extension pT3a: Extraprostatic extension or microscopic invasion of bladder neck pT3b: Seminal vesicle invasion pT4: Invasion of rectum, levator muscles, and/or pelvic wall pTX: Primary tumor cannot be assessed INCLUSION CRITERIA: All patients TIMING: Baseline REPORTING SOURCE: Clinical TYPE: Single answer

Data type

integer

Alias
UMLS CUI [1,1]
C0600139
UMLS CUI [1,2]
C1300072
UMLS CUI [1,3]
C1521733
Indicate the pathological nodal stage (per AJCC 7th)
Description

Pathologic staging preferred, if available pN0: No positive regional nodes pN1: Metastases in regional node(s) pNX: Regional nodes not sampled INCLUSION CRITERIA: All patients TIMING: Baseline REPORTING SOURCE: Clinical TYPE: Single answer

Data type

integer

Alias
UMLS CUI [1,1]
C0600139
UMLS CUI [1,2]
C0456532
UMLS CUI [1,3]
C1521733
Indicate if a Gleason score was recorded at time of initial diagnosis
Description

INCLUSION CRITERIA: All patients TIMING: Baseline REPORTING SOURCE: Clinical TYPE: Single answer

Data type

integer

Alias
UMLS CUI [1]
C0332326
If yes, indicate the primary Gleason score at time of initial diagnosis
Description

INCLUSION CRITERIA: All patients, If answered 'yes' on Gleason score (GLEASON) TIMING: Baseline REPORTING SOURCE: Clinical TYPE: Numerical value RESPONSE OPTIONS: 2-10

Data type

integer

Alias
UMLS CUI [1,1]
C0332326
UMLS CUI [1,2]
C1273604
If yes, indicate the secondary Gleason score at time of initial diagnosis
Description

INCLUSION CRITERIA: All patients, If answered 'yes' on Gleason score (GLEASON) TIMING: Baseline REPORTING SOURCE: Clinical TYPE: Numerical value RESPONSE OPTIONS: 2-10

Data type

integer

Alias
UMLS CUI [1,1]
C0332326
UMLS CUI [1,2]
C1273605
Provide site of metastatic disease
Description

INCLUSION CRITERIA: All patients TIMING: Baseline REPORTING SOURCE: Clinical TYPE: Single answer

Data type

integer

Alias
UMLS CUI [1]
C0807944
Provide extent of metastatic disease
Description

High burden is indicated as any of the following criteria (from: CHAARTED (randomized clinical trial in the US): - Visceral metastases (extranodal) - Bone metastases with at least 4 bone lesions OR at least 1 bone lesion outside of the vertebral column or pelvis. INCLUSION CRITERIA: All patients TIMING: Baseline REPORTING SOURCE: Clinical TYPE: Single answer

Data type

integer

Alias
UMLS CUI [1]
C0449279
Treatment Factors
Description

Treatment Factors

Alias
UMLS CUI-1
C0679853
Indicate if the patient has had a prior prostatectomy
Description

INCLUSION CRITERIA: All patients TIMING: Baseline REPORTING SOURCE: Clinical TYPE: Single answer

Data type

integer

Alias
UMLS CUI [1,1]
C1514463
UMLS CUI [1,2]
C0033573
Indicate date of prostatectomy
Description

INCLUSION CRITERIA: All patients, If answered 'yes' on prior prostatectomy (prostatectx) TIMING: Baseline REPORTING SOURCE: Clinical TYPE: Date by DD/MM/YYYY

Data type

date

Measurement units
  • DD/MM/YYYY
Alias
UMLS CUI [1,1]
C1514463
UMLS CUI [1,2]
C0033573
UMLS CUI [1,3]
C0011008
DD/MM/YYYY
Indicate if the patient has had prior radiation as primary treatment for prostate cancer (prostate bed, not palliative radiation)
Description

INCLUSION CRITERIA: All patients TIMING: Baseline REPORTING SOURCE: Clinical TYPE: Single answer

Data type

integer

Alias
UMLS CUI [1,1]
C0279134
UMLS CUI [1,2]
C1708063
Indicate if the patient has had prior radiation as adjuvant / salvage therapy for prostate cancer (prostate bed, not palliative radiation)
Description

INCLUSION CRITERIA: All patients TIMING: Baseline REPORTING SOURCE: Clinical TYPE: Single answer

Data type

integer

Alias
UMLS CUI [1,1]
C0279134
UMLS CUI [1,2]
C1706721
UMLS CUI [2,1]
C0279134
UMLS CUI [2,2]
C0085405
Indicate if the patient has had treatment with ADT
Description

Use of any of the following treatments to induce castrate levels of serum testosterone: 1. LHRH or GnRH agonist or antagonist 2. Bilateral orchiectomies INCLUSION CRITERIA: All patients TIMING: Baseline REPORTING SOURCE: Clinical TYPE: Single answer

Data type

integer

Alias
UMLS CUI [1]
C0279492
Indicate systemic therapies used in the past other than ADT
Description

Any medication that treats the prostate cancer taken by mouth, through a vein, or injected, other than ADT INCLUSION CRITERIA: All patients TIMING: Baseline REPORTING SOURCE: Clinical TYPE: Single answer

Data type

integer

Alias
UMLS CUI [1,1]
C1515119
UMLS CUI [1,2]
C1514463
Indicate the receipt of anti-resorptive medications or denosumab
Description

Both anti-resorptive medications or denosumab are relevant INCLUSION CRITERIA: All patients TIMING: Baseline REPORTING SOURCE: Clinical TYPE: Single answer

Data type

integer

Alias
UMLS CUI [1]
C0012544
UMLS CUI [2]
C3839270
Back to the top of the page

Similar models

Baseline Clinical Form

1 forms
  1. StudyEvent: ODM
    1. Baseline Clinical Form
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
Administrative Data
C1320722 (UMLS CUI-1)
Patient ID
Item
Indicate the patient's medical record number
integer
C1269815 (UMLS CUI [1])
Item Group
Demographic Factors
C1704791 (UMLS CUI-1)
Date of birth
Item
What is your date of birth?
date
C0421451 (UMLS CUI [1])
Height
Item
Indicate height in centimeters or inches
float
C0005890 (UMLS CUI [1])
Item
Indicate units of height
integer
C0005890 (UMLS CUI [1,1])
C1519795 (UMLS CUI [1,2])
Height units
Code List
Indicate units of height
CL Item
centimeters (1)
C0475210 (UMLS CUI-1)
(Comment:en)
CL Item
inches (2)
C0439204 (UMLS CUI-1)
(Comment:en)
Weight
Item
Indicate weight in kilograms or pounds
float
C0005910 (UMLS CUI [1])
Item
Indicate units of weight
integer
C0005910 (UMLS CUI [1,1])
C1519795 (UMLS CUI [1,2])
Pathological tumor stage
Code List
Indicate units of weight
CL Item
kilograms (1)
C0439209 (UMLS CUI-1)
(Comment:en)
CL Item
pounds (2)
C0439219 (UMLS CUI-1)
(Comment:en)
Item Group
Baseline Clinical Factors
C0449440 (UMLS CUI-1)
C1442488 (UMLS CUI-2)
Hemoglobin level at APC diagnosis
Item
Indicate hemoglobin level at time of APC diagnosis
float
C0518015 (UMLS CUI [1,1])
C0011900 (UMLS CUI [1,2])
Item Group
Baseline Tumor Factors
C0475752 (UMLS CUI-1)
C1442488 (UMLS CUI-2)
PSA level at APC diagnosis
Item
Indicate PSA value at time of APC diagnosis
float
C0201544 (UMLS CUI [1])
Item
Indicate the clinical tumor stage (per AJCC 7th)
integer
C0600139 (UMLS CUI [1,1])
C1300072 (UMLS CUI [1,2])
C0205210 (UMLS CUI [1,3])
Clinical tumor stage
Code List
Indicate the clinical tumor stage (per AJCC 7th)
CL Item
cT0  (0)
C1275863 (UMLS CUI-1)
C0475371 (UMLS CUI-2)
(Comment:en)
CL Item
cT1 (1)
C1275863 (UMLS CUI-1)
C0475372 (UMLS CUI-2)
(Comment:en)
CL Item
cT1a (2)
C1275863 (UMLS CUI-1)
C0475383 (UMLS CUI-2)
(Comment:en)
CL Item
cT1b (3)
C1275863 (UMLS CUI-1)
C0475385 (UMLS CUI-2)
(Comment:en)
CL Item
cT1c (4)
C1275863 (UMLS CUI-1)
C0475386 (UMLS CUI-2)
(Comment:en)
CL Item
cT2  (5)
C1275863 (UMLS CUI-1)
C0475373 (UMLS CUI-2)
(Comment:en)
CL Item
cT2a (6)
C1275863 (UMLS CUI-1)
C0475387 (UMLS CUI-2)
(Comment:en)
CL Item
cT2b  (7)
C1275863 (UMLS CUI-1)
C0475387 (UMLS CUI-2)
(Comment:en)
CL Item
cT2c  (8)
C1275863 (UMLS CUI-1)
C0475389 (UMLS CUI-2)
(Comment:en)
CL Item
cT3  (9)
C1275863 (UMLS CUI-1)
C0475374 (UMLS CUI-2)
(Comment:en)
CL Item
cT3a (10)
C1275863 (UMLS CUI-1)
C0475390 (UMLS CUI-2)
(Comment:en)
CL Item
cT3b (11)
C1275863 (UMLS CUI-1)
C0475391 (UMLS CUI-2)
(Comment:en)
CL Item
cT4 (12)
C1275863 (UMLS CUI-1)
C0475751 (UMLS CUI-2)
(Comment:en)
CL Item
cTX (13)
C1275863 (UMLS CUI-1)
C0332377 (UMLS CUI-2)
(Comment:en)
CL Item
Unknown (999)
C1275863 (UMLS CUI-1)
C0439673 (UMLS CUI-2)
(Comment:en)
Item
Indicate the clinical nodal stage (per AJCC 7th)
integer
C0600139 (UMLS CUI [1,1])
C0456532 (UMLS CUI [1,2])
C0205210 (UMLS CUI [1,3])
Clinical nodal stage
Code List
Indicate the clinical nodal stage (per AJCC 7th)
CL Item
N0  (0)
C1275865 (UMLS CUI-1)
C0441959 (UMLS CUI-2)
(Comment:en)
CL Item
N1  (1)
C1275865 (UMLS CUI-1)
C0441962 (UMLS CUI-2)
(Comment:en)
CL Item
NX  (2)
C1275865 (UMLS CUI-1)
C0445085 (UMLS CUI-2)
(Comment:en)
CL Item
Unknown (999)
C1275865 (UMLS CUI-1)
C0439673 (UMLS CUI-2)
(Comment:en)
Item
Indicate the pathological tumor stage (per AJCC 7th)
integer
C0600139 (UMLS CUI [1,1])
C1300072 (UMLS CUI [1,2])
C1521733 (UMLS CUI [1,3])
Pathological tumor stage
Code List
Indicate the pathological tumor stage (per AJCC 7th)
CL Item
pT2  (1)
C0332392 (UMLS CUI-1)
(Comment:en)
CL Item
pT2a  (2)
C2732270 (UMLS CUI-1)
(Comment:en)
CL Item
pT2b  (3)
C2733080 (UMLS CUI-1)
(Comment:en)
CL Item
pT2c  (4)
C2733081 (UMLS CUI-1)
(Comment:en)
CL Item
pT3 (5)
C0332393 (UMLS CUI-1)
(Comment:en)
CL Item
pT3a  (6)
C2733390 (UMLS CUI-1)
(Comment:en)
CL Item
pT3b  (7)
C2732522 (UMLS CUI-1)
(Comment:en)
CL Item
pT4  (8)
C0332394 (UMLS CUI-1)
(Comment:en)
CL Item
pTX (9)
C0332395 (UMLS CUI-1)
(Comment:en)
CL Item
Unknown (999)
C0439673 (UMLS CUI-1)
C1272834 (UMLS CUI-2)
(Comment:en)
Item
Indicate the pathological nodal stage (per AJCC 7th)
integer
C0600139 (UMLS CUI [1,1])
C0456532 (UMLS CUI [1,2])
C1521733 (UMLS CUI [1,3])
Pathological nodal stage
Code List
Indicate the pathological nodal stage (per AJCC 7th)
CL Item
pN0  (0)
C0332396 (UMLS CUI-1)
(Comment:en)
CL Item
pN1 (1)
C0332397 (UMLS CUI-1)
(Comment:en)
CL Item
pNX (2)
C0332401 (UMLS CUI-1)
(Comment:en)
CL Item
Unknown (999)
C0439673 (UMLS CUI-1)
C1272833 (UMLS CUI-2)
(Comment:en)
Item
Indicate if a Gleason score was recorded at time of initial diagnosis
integer
C0332326 (UMLS CUI [1])
Pathological nodal stage
Code List
Indicate if a Gleason score was recorded at time of initial diagnosis
CL Item
Yes (1)
C1705108 (UMLS CUI-1)
(Comment:en)
CL Item
No (0)
C1298908 (UMLS CUI-1)
(Comment:en)
CL Item
Unknown (999)
C0439673 (UMLS CUI-1)
(Comment:en)
Gleason score at time of initial diagnosis: Primary
Item
If yes, indicate the primary Gleason score at time of initial diagnosis
integer
C0332326 (UMLS CUI [1,1])
C1273604 (UMLS CUI [1,2])
Gleason score at time of initial diagnosis: Secondary
Item
If yes, indicate the secondary Gleason score at time of initial diagnosis
integer
C0332326 (UMLS CUI [1,1])
C1273605 (UMLS CUI [1,2])
Item
Provide site of metastatic disease
integer
C0807944 (UMLS CUI [1])
Site of metastatic disease
Code List
Provide site of metastatic disease
CL Item
No metastasis (0)
C0027627 (UMLS CUI-1)
C1298908 (UMLS CUI-2)
(Comment:en)
CL Item
Bone only (1)
C0153690 (UMLS CUI-1)
C0205171 (UMLS CUI-2)
(Comment:en)
CL Item
Lymph node only (2)
C0806692 (UMLS CUI-1)
C0205171 (UMLS CUI-2)
(Comment:en)
CL Item
Visceral only (3)
C0027627 (UMLS CUI-1)
C0442045 (UMLS CUI-2)
C0205171 (UMLS CUI-3)
(Comment:en)
CL Item
Combination (4)
C0205195 (UMLS CUI-1)
C0027627 (UMLS CUI-2)
(Comment:en)
Item
Provide extent of metastatic disease
integer
C0449279 (UMLS CUI [1])
Extent of metastatic disease
Code List
Provide extent of metastatic disease
CL Item
No metastasis (0)
C0027627 (UMLS CUI-1)
C1298908 (UMLS CUI-2)
(Comment:en)
CL Item
Low burden (1)
C0027627 (UMLS CUI-1)
C1449699 (UMLS CUI-2)
C0205251 (UMLS CUI-3)
(Comment:en)
CL Item
High burden (2)
C0027627 (UMLS CUI-1)
C1449699 (UMLS CUI-2)
C0205250 (UMLS CUI-3)
(Comment:en)
Item Group
Treatment Factors
C0679853 (UMLS CUI-1)
Item
Indicate if the patient has had a prior prostatectomy
integer
C1514463 (UMLS CUI [1,1])
C0033573 (UMLS CUI [1,2])
Question 2 of additional libido and use of sexual aids questions
Code List
Indicate if the patient has had a prior prostatectomy
CL Item
No (0)
C1298908 (UMLS CUI-1)
(Comment:en)
CL Item
Yes (1)
C1705108 (UMLS CUI-1)
(Comment:en)
Date of prior prostatectomy
Item
Indicate date of prostatectomy
date
C1514463 (UMLS CUI [1,1])
C0033573 (UMLS CUI [1,2])
C0011008 (UMLS CUI [1,3])
Item
Indicate if the patient has had prior radiation as primary treatment for prostate cancer (prostate bed, not palliative radiation)
integer
C0279134 (UMLS CUI [1,1])
C1708063 (UMLS CUI [1,2])
Prior radiation therapy: Primary treatment
Code List
Indicate if the patient has had prior radiation as primary treatment for prostate cancer (prostate bed, not palliative radiation)
CL Item
No (0)
C1298908 (UMLS CUI-1)
(Comment:en)
CL Item
Yes, 1-3 years ago (1)
C3843820 (UMLS CUI-1)
(Comment:en)
CL Item
Yes, > 3 years ago (2)
C3843819 (UMLS CUI-1)
(Comment:en)
Item
Indicate if the patient has had prior radiation as adjuvant / salvage therapy for prostate cancer (prostate bed, not palliative radiation)
integer
C0279134 (UMLS CUI [1,1])
C1706721 (UMLS CUI [1,2])
C0279134 (UMLS CUI [2,1])
C0085405 (UMLS CUI [2,2])
Prior radiation therapy: Primary treatment
Code List
Indicate if the patient has had prior radiation as adjuvant / salvage therapy for prostate cancer (prostate bed, not palliative radiation)
CL Item
No (0)
C1298908 (UMLS CUI-1)
(Comment:en)
CL Item
Yes, 1-3 years ago (1)
C3843820 (UMLS CUI-1)
(Comment:en)
CL Item
Yes, > 3 years ago (2)
C3843819 (UMLS CUI-1)
(Comment:en)
Item
Indicate if the patient has had treatment with ADT
integer
C0279492 (UMLS CUI [1])
Prior radiation therapy: Primary treatment
Code List
Indicate if the patient has had treatment with ADT
CL Item
No (0)
C1298908 (UMLS CUI-1)
(Comment:en)
CL Item
Yes, with bilateral orchiectomies (1)
C1705108 (UMLS CUI-1)
C3698192 (UMLS CUI-2)
(Comment:en)
CL Item
Yes, with LHRH or GnRH agonist or antagonist in the past (2)
C1705108 (UMLS CUI-1)
C1514463 (UMLS CUI-2)
C1518041 (UMLS CUI-3)
C0023610 (UMLS CUI-4)
C0003139 (UMLS CUI-5)
C2267073 (UMLS CUI-6)
C1268855 (UMLS CUI-7)
(Comment:en)
CL Item
Yes, with LHRH or GnRH agonist or antagonist currently (3)
C1705108 (UMLS CUI-1)
C0521116 (UMLS CUI-2)
C1518041 (UMLS CUI-3)
C0023610 (UMLS CUI-4)
C0003139 (UMLS CUI-5)
C2267073 (UMLS CUI-6)
C1268855 (UMLS CUI-7)
(Comment:en)
Item
Indicate systemic therapies used in the past other than ADT
integer
C1515119 (UMLS CUI [1,1])
C1514463 (UMLS CUI [1,2])
Prior radiation therapy: Primary treatment
Code List
Indicate systemic therapies used in the past other than ADT
CL Item
No (0)
C1298908 (UMLS CUI-1)
(Comment:en)
CL Item
Yes, 1 therapy used (1)
C1705108 (UMLS CUI-1)
C1515119 (UMLS CUI-2)
C0205447 (UMLS CUI-3)
(Comment:en)
CL Item
Yes, 2 therapies used (2)
C1705108 (UMLS CUI-1)
C1515119 (UMLS CUI-2)
C0205448 (UMLS CUI-3)
(Comment:en)
CL Item
Yes, ≥ 3 therapies used (3)
C1705108 (UMLS CUI-1)
C1515119 (UMLS CUI-2)
C0205449 (UMLS CUI-3)
C1524031 (UMLS CUI-4)
(Comment:en)
Item
Indicate the receipt of anti-resorptive medications or denosumab
integer
C0012544 (UMLS CUI [1])
C3839270 (UMLS CUI [2])
Question 2 of additional libido and use of sexual aids questions
Code List
Indicate the receipt of anti-resorptive medications or denosumab
CL Item
No (0)
C1298908 (UMLS CUI-1)
(Comment:en)
CL Item
Yes (1)
C1705108 (UMLS CUI-1)
(Comment:en)
Back to the top of the page 

Contact

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial